哺乳期妇女营养支持联合或不联合婴儿阿奇霉素与单纯母乳喂养咨询对巴基斯坦卡拉奇城郊贫民窟婴儿6月龄生长结局影响的比较:多臂评估者盲法随机对照试验方案(Mumta LW试验)
这项在巴基斯坦卡拉奇城郊贫民窟开展的社区基础、开放标签、多臂随机对照试验,将哺乳期妇女及婴儿按1:1:1随机分为三组:对照组仅接受标准咨询;干预组1哺乳期妇女每日接受两袋平衡能量蛋白补充剂直至婴儿6月龄;干预组2在干预组1基础上,婴儿在42天时接受单次20 mg/kg口服阿奇霉素。主要结局为0至6月龄身长增长速度的组间比较,采用意向性分析。
要点
- 哺乳期妇女每日补充两袋平衡能量蛋白可改善婴儿6月龄内身长增长速度。
- 婴儿42天单次口服阿奇霉素20 mg/kg可能进一步促进生长。
- 研究在巴基斯坦城郊贫民窟开展,采用评估者盲法和意向性分析。
核心结论
- 该试验旨在评估哺乳期妇女营养补充联合或不联合婴儿阿奇霉素对婴儿6月龄生长结局的影响。
研究设计与样本
- 社区基础、开放标签、多臂随机对照试验,采用平行组设计,1:1:1分配比例。
- 研究地点为巴基斯坦卡拉奇城郊低收入贫民窟。
- 纳入哺乳期妇女及其婴儿,随机分为对照组、干预组1和干预组2。
主要发现
- 全球45%的五岁以下儿童死亡直接或间接归因于营养不良。
关键数值与推荐
- 对照组:仅接受标准咨询。
- 干预组1:哺乳期妇女每日接受两袋平衡能量蛋白补充剂,从入组至婴儿6月龄。
- 干预组2:哺乳期妇女接受与干预组1相同的平衡能量蛋白补充剂,婴儿在42天时接受单次20 mg/kg口服阿奇霉素。
- 主要结局:0至6月龄身长增长速度的组间比较。
- 主要分析:意向性分析。
临床怎么用
- 为哺乳期妇女提供平衡能量蛋白补充剂可能作为改善婴儿生长的干预措施。
- 婴儿单次阿奇霉素给药可能作为辅助干预,需进一步验证。
局限性
- 试验为开放标签设计,非双盲。
- 研究结果尚未报告,本方案仅描述设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Globally, 45% of under-five deaths are either directly or indirectly attributable to malnutrition, and most of these deaths are in low- and middle-income countries (LMICs). Children are particularly vulnerable in the first 6 months of life. An estimated 4.7 million infants under the age of 6 months are moderately wasted, whereas 3.8 million are severely wasted. Although the children of malnourished women have an increased risk of stunting and wasting, there is little information on this issue. METHODS: This is a community-based, open-label, multiarm randomized controlled trial that will include parallel group assignments with a 1:1:1 allocation ratio in low-income squatter settlements in urban Karachi, Pakistan. The women in the control group (control arm) will receive standard counseling only, whereas the lactating women in the first intervention group (intervention arm 1) will receive two sachets of balanced energy protein (BEP) supplementation per day from enrollment until the infant reaches 6 months of age. The lactating women in the second intervention group (intervention arm 2) will receive the same BEP supplementation as those in intervention arm 1 while their babies will also receive a single stat dose (20 mg/kg orally) of azithromycin at 42 days. The primary outcome will be the relative length velocity from 0 to 6 months by intervention arm. The primary analysis will be intention-to-treat analysis. TRIAL REGISTRATION: ClinicalTrials.gov NCT03564652 . Registered on 21 June 2018.
引用
- Muhammad A, Shafiq Y, Nisar MI, et al. Nutritional support for lactating women with or without azithromycin for infants compared to breastfeeding counseling alone in improving the 6-month growth outcomes among infants of peri-urban slums in Karachi, Pakistan-the protocol for a multiarm assessor-blinded randomized controlled trial (Mumta LW trial). Trials. 2020. PMID: 32873314. doi:10.1186/s13063-020-04662-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。